Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3525396016 | Product containing papaveretum and scopolamine hydrobromide (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3525397013 | Product containing papaveretum and scopolamine hydrobromide | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3666453017 | Hyoscine hydrobromide and papaveretum product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3666454011 | Papaveretum and scopolamine hydrobromide product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing papaveretum and scopolamine hydrobromide (medicinal product) | est un(e) (attribut) | Product containing papaveretum (medicinal product) | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide (medicinal product) | a pour principe actif (attribut) | Opium preparation (substance) | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide (medicinal product) | a pour principe actif (attribut) | Papaveretum (substance) | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide (medicinal product) | a pour principe actif (attribut) | Central nervous system agent (substance) | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide (medicinal product) | a pour principe actif (attribut) | Opium | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide (medicinal product) | est un(e) (attribut) | Hyoscine hydrobromide (product) | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide (medicinal product) | a pour principe actif (attribut) | Scopolamine hydrobromide (substance) | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide (medicinal product) | est un(e) (attribut) | Scopolamine hydrobromide (product) | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide (medicinal product) | est un(e) (attribut) | Product containing scopolamine in parenteral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide (medicinal product) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide (medicinal product) | est un(e) (attribut) | Product containing scopolamine (medicinal product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule (product) | est un(e) (attribut) | False | Product containing papaveretum and scopolamine hydrobromide (medicinal product) | Inferred relationship | Some | |
| Papaveretum 15.4 mg/mL and scopolamine hydrobromide 400 microgram/mL solution for injection ampule | est un(e) (attribut) | False | Product containing papaveretum and scopolamine hydrobromide (medicinal product) | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
Concept inactivation indicator reference set
Description inactivation indicator reference set
FHIR